메뉴 건너뛰기




Volumn 10, Issue SUPPL. 1, 2005, Pages 12-18

Belara® - A reliable oral contraceptive with additional benefits for health and efficacy in dysmenorrhoea

Author keywords

Acne; Compliance; Dysmenorrhea; Ethinylestradiol chlormadinone acetate; Menstrual irregularities; Oral contraceptive

Indexed keywords

CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; CHLORMADINONE ACETATE; ETHINYLESTRADIOL;

EID: 29044442795     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180500434897     Document Type: Conference Paper
Times cited : (19)

References (6)
  • 1
    • 0037383049 scopus 로고    scopus 로고
    • A 12-month evaluation of the CMA-containing oral contraceptive Belara®: Efficacy, tolerability and anti-androgenic properties
    • Schramm G, Steffens D. A 12-month evaluation of the CMA-containing oral contraceptive Belara®: efficacy, tolerability and anti-androgenic properties. Contraception 2003;67:305-12.
    • (2003) Contraception , vol.67 , pp. 305-312
    • Schramm, G.1    Steffens, D.2
  • 2
    • 0034078616 scopus 로고    scopus 로고
    • Zyklusabhängige Befindlichkeitsstörungen der Frau
    • Zahradnik HP, Wetzka B, Schuth W. Zyklusabhängige Befindlichkeitsstörungen der Frau. Gynäkologe 2000;33:225-38.
    • (2000) Gynäkologe , vol.33 , pp. 225-238
    • Zahradnik, H.P.1    Wetzka, B.2    Schuth, W.3
  • 5
    • 0034838348 scopus 로고    scopus 로고
    • Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara®) and EE/LNG (Microgynon®)
    • Worret I, Arp W, Zahradnik HP, et al. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara®) and EE/LNG (Microgynon®). Dermatology 2001;203:38-44.
    • (2001) Dermatology , vol.203 , pp. 38-44
    • Worret, I.1    Arp, W.2    Zahradnik, H.P.3
  • 6
    • 0031958753 scopus 로고    scopus 로고
    • Efficacy and safety of the new anti-androgenic oral contraceptive Belara®
    • Zahradnik HP, Goldberg J, Andreas J-O. Efficacy and safety of the new anti-androgenic oral contraceptive Belara®. Contraception 1998;57:103-9.
    • (1998) Contraception , vol.57 , pp. 103-109
    • Zahradnik, H.P.1    Goldberg, J.2    Andreas, J.-O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.